Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CytomX Therapeutics Announces Closing of Public Offering of Common Stock
-
CytomX Therapeutics (CTMX) Prices 14.286M Share Common Offering at $7/Sh
-
CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
-
CytomX Therapeutics (CTMX) Announces Proposed $75M Common Share Offering
-
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
-
CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference
-
CytomX to Present at Upcoming Healthcare Conferences
-
CytomX to Present at Upcoming Investor Conferences
-
CytomX Therapeutics to Present at Upcoming Investor Conferences
-
CytomX to Present at Cowen and Company’s 36th Annual Health Care Conference
-
Cowen Starts CytomX Therapeutics (CTMX) at Outperform
-
CytomX Therapeutics (CTMX) Closes 7.67M Common Stock IPO at $12/Share
-
CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
CytomX Therapeutics (CTMX) IPO Opens Sharply Higher, Pares Gains
-
CytomX Therapeutics (CTMX) IPO Prices at $12, Below Expected Range
-
CytomX Announces Pricing of Initial Public Offering
-
CytomX Therapeutics (CTMX) Sees IPO Price of $14 - $16/Share
-
CytomX Therapeutics (CTMX) Files $100M Common Stock IPO
-
CytomX Files Registration Statement for Proposed Initial Public Offering
